Oligometastatic Prostate Cancer (OMPC) trials recruiting in Illinois

Fewer than 3 recruiting trials found.

All Oligometastatic Prostate Cancer (OMPC) trials nationally

Cities in Illinois

Recruiting trials in Illinois

• An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
  NCT05939414 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: Male · Illinois: Chicago, Elk Grove